Status:
TERMINATED
NO Prevention of COVID-19 for Healthcare Providers
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Coronavirus Infections
Healthcare Associated Infection
Eligibility:
All Genders
18-99 years
Phase:
PHASE2
Brief Summary
Thousands of healthcare workers have been infected with SARS-CoV-2 and contracted COVID-19 despite their best efforts to prevent contamination. No proven vaccine is available to protect healthcare wor...
Detailed Description
In their efforts to provide care for patients with novel coronavirus (SARS-CoV-2) disease (COVID-19) infection, many healthcare workers around the globe exposed to SARS-CoV-2 got infected and died ove...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Scheduled to work with SARS-CoV-2 infected patients for at least 3 days in a week.
Exclusion
- Previous documented SARS-CoV-2 infections and subsequent negative SARS-CoV-2 rt-PCR test.
- Pregnancy
- Known hemoglobinopathies.
- Known anemia
Key Trial Info
Start Date :
April 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04312243
Start Date
April 7 2020
End Date
January 10 2022
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114